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Abstract
Background Oxytocin administration may increase attention
to emotional information. We hypothesized that this augment-
ed emotional processing might in turn lead to interference on
concurrent cognitive tasks. To test this hypothesis, we exam-
ined whether oxytocin administration would lead to height-
ened emotional interference during a working memory para-
digm. Additionally, moderating effects of childhood maltreat-
ment were explored.
Methods Seventy-eight healthy males received 24 IU of intra-
nasal oxytocin or placebo in a randomized placebo-controlled
double-blind between-subjects study. Aworking memory task
was performed during which neutral, positive, and negative
distractors were presented.
Results The main outcome observed was that oxytocin did not
enhance interference by emotional information during the
working memory task. There was a non-significant trend for
oxytocin to slow down performance irrespective of distractor
valence, while accuracy was unaffected. Exploratory analyses
showed that childhood maltreatment was related to lower over-
all accuracy, but in the placebo condition only. However, the
maltreated group sample size was very small precluding any
conclusions on its moderating effect.
Conclusions Despite oxytocin’s previously proposed role in
enhanced emotional processing, no proof was found that this
would lead to reduced performance on a concurrent cognitive
task. The routes bywhich oxytocin exerts its effects on cognitive
and social-emotional processes remain to be fully elucidated.
Keywords Oxytocin .Workingmemory . Emotion .
Interference . Distractor . Childhoodmaltreatment
Introduction
Oxytocin research has received much attention in recent years
due to its positive role in social behaviors including pair bond-
ing, trust, social memory, and anxiety (Heinrichs et al. 2009;
Macdonald and Macdonald 2010; Meyer-Lindenberg et al.
2011). These effects have raised the possibility of a host of
therapeutic applications (Guastella et al. 2009a; Koch et al.
2014; McQuaid et al. 2014). Oxytocin administration has
been hypothesized to increase socially oriented or approach-
related behaviors (Harari-Dahan and Bernstein 2014; Kemp
and Guastella 2010; Radke et al. 2013; Shamay-Tsoory and
Abu-Akel 2016), which may be due to increased salience of
emotions and/or enhanced emotion recognition (Shahrestani
et al. 2013; Van IJzendoorn and Bakermans-Kranenburg
2012). However, while oxytocin is often assumed to have
positive, pro-social effects, recent findings also indicate that
under certain circumstances oxytocin administration can have
less beneficial or even anti-social effects, such as enhanced
aggression, anxiety, or distrust (De Dreu et al. 2010;
MacDonald et al. 2013; Radke and de Bruijn 2012). This
may depend on contextual and personal factors (Bartz et al.
2011; Carter 2014; Harari-Dahan and Bernstein 2014).
Clearly, before oxytocin administration can be introduced as
a possible new therapy in clinical practice, its working mech-
anisms and potential moderators should be carefully studied.
While many studies have focused on the effects of oxytocin
on complex social behaviors, recent evidence indicates that
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oxytocin may already act on early emotional attention pro-
cesses (Domes et al. 2013; Ellenbogen et al. 2012, 2013;
Prehn et al. 2013; Ruissen and de Bruijn 2015), which could
underlie changes in more complex social behaviors. In a pre-
vious study, we showed that oxytocin administration in
healthy young men led to enhanced orienting of attention in
response to emotional (both happy and fearful) gaze cues
(Tollenaar et al. 2013). Others have also shown that oxytocin
administration may enhance the processing of social or emo-
tional information at early, more automatic stages by enhanc-
ing detection accuracy of emotional expressions (Schulze
et al. 2011), increasing recruitment of attentional resources
(Prehn et al. 2013), and by directing covert attention to social
cues (Domes et al. 2013). Some of these studies found the
effects to be more pronounced for positive emotions (Domes
et al. 2013; Schulze et al. 2011), and Ellenbogen et al. (2012)
even showed an attenuated emotional bias for negative emo-
tions. Null findings have been reported as well (Guastella et al.
2009b), showing that the effects of oxytocin may be task and
valence specific. Hence, more research is needed to clarify the
emotional attention effects of oxytocin.
While enhanced attention to emotional information may en-
hance social processes, it could potentially also interfere with
concurrent cognitive processes (Cromheeke andMueller 2014).
Previous work in our group has shown that emotionally arous-
ing information can interfere with working memory perfor-
mance (Oei et al. 2010, 2012), and that this interference may
be more severe in disorders characterized by emotional
dysregulations (Krause-Utz et al. 2012). Increased processing
of emotions due to oxytocin administration in such contexts
might lead to even stronger interference of cognitive process-
ing. A study by Ellenbogen et al. (2013) showed reduced inhi-
bition of sad facial expressions in participants scoring high on
depressive symptoms after oxytocin administration, pointing to
possible interference by emotions on an automatic cognitive
process. Enhanced distractibility by emotions due to oxytocin
could give contraindications of oxytocin administration in pa-
tient groups, or in situations where emotional distractors are
present while cognitive performance is of importance.
In the current study, we therefore examined whether intrana-
sal oxytocin administration would enhance interference by
emotional (positive and negative) information during a concur-
rent working memory task, which has previously been shown
to be sensitive to emotional distraction (Krause-Utz et al. 2012;
Oei et al. 2010, 2012). We hypothesized that intranasal oxyto-
cin administration would enhance interference by emotional
(positive and negative) information during the working memo-
ry task, as indicated by an increase in reaction times and/or
errors (i.e., reduced accuracy) in a healthy male population.
Furthermore, as mentioned previously, the effects of oxytocin
may depend on contextual and personal factors. One factor that
could be an important moderator of the effects of oxytocin is the
experience of early life stress, including childhoodmaltreatment.
Early life stress has been related to reduced (or less beneficial)
effects of oxytocin on pro-social behavior, neural and biological
responses (Fan et al. 2014; Grimm et al. 2014; Van IJzendoorn
et al. 2011), which could be due to early life stress-related chang-
es in the oxytocinergic system (Heim et al. 2009b). In the current
study, we therefore additionally want to explore the possible
moderating effects of childhood maltreatment on the effects of
oxytocin administration.
Material and methods
Participants
Seventy-eight Dutch healthy male volunteers participated in
the study. Only males were included due to additional social
paradigms included in the full study protocol (see also Ruissen
and de Bruijn (2015)). Exclusion criteria were use of medica-
tion, medical or physical illness, current psychiatric problems,
excessive drug or alcohol use, and excessive smoking (> 15
cigarettes per day), based on self-report. Three participants
(two in the placebo and one in the oxytocin condition) were
excluded from analyses, because they did not follow the in-
structions of the working memory task (> 50% errors). Data of
the remaining 75 participants (mean age = 22.6 years,
SD = 3.6, range = 18–35) were included in the analyses. All
participants signed informed consent and received a payment
of 20 euros for their participation.
Procedures
A double-blind placebo-controlled between-subjects design
was used. Participants were randomly assigned to either the
oxytocin (N = 39, mean age = 22.3, SD = 3.1) or the placebo
condition (N = 36, mean age = 22.8, SD = 4.1,F(1, 73) = 4.64,
p = .55). Randomization was performed and controlled by the
pharmacy of the Leiden University Medical Center (LUMC).
Participants in the oxytocin condition received a nasal spray
containing oxytocin (Defiante Farmaceutica, Sigma-Tau).
Participants in the placebo condition received a nasal spray
containing a solution of sodium chloride. Participants self-
administered six puffs (three in each nostril), resulting in a
total of 24 intranasal units (IU). This dose has been shown
to induce both behavioral and cognitive effects (Quintana
et al. 2015; Shahrestani et al. 2013). Participants came to the
lab in pairs for a test session, which included a social interac-
tion task, an EEG paradigm (Ruissen and de Bruijn 2015), and
the emotional working memory task described here. The cur-
rent task was performed last in the study protocol, as the emo-
tional distractors used in this working memory paradigm can
be perceived as stressful and could have influenced later tests.
Hence, approximately 80 min after oxytocin/placebo
administration, the emotional working memory task was
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performed individually. Previous studies have shown that
oxytocin stays detectable in saliva up to 7 h after administra-
tion (van IJzendoorn et al. 2012), and physiological and
emotional effects have been reported after similar time spans
(Olff et al. 2013). Procedures were in accordance with the
Declaration of Helsinki and approved by the Leiden
University Medical Ethics Committee.
Measures
Emotional working memory task
The EWMT is an adapted Sternberg item recognition task,
which has repeatedly shown interference by emotional infor-
mation on working memory performance in both healthy and
clinical samples (Krause-Utz et al. 2012; Oei et al. 2010,
2012). The overall goal of this task is for participants to mem-
orize a list of letters and then to check in a new list of letters
whether they recognize one of the previously shown letters.
The time interval between the two lists is used to present
distracting information, in this case pictures of different
valences. The current paradigm consisted of 72 trials, each
starting with a black fixation block for 750 ms, followed by
the presentation of three black letters below each other (mem-
oranda, 1000 ms). After a delay interval (1500 ms), three
letters were again displayed (probe, ≤ 2000 ms). In half of
the trials, one of the three memoranda (target) was present in
the probe. Participants had to press a Byes^ or Bno^ button
indicating whether they had recognized a target or not.
Participants had to respond within the 2000 ms during which
the probe was presented, which would start the next trial.
During the delay interval, neutral, positively, or negatively
arousing pictures from the International Affective Picture
System (IAPS, Lang et al. 2008) were presented as distractors.
The positive and negative pictures mainly included social
scenes and human body parts, while the neutral pictures in-
cluded natural scenes and objects. The 24 positive, negative,
and neutral pictures were randomly displayed. The inter-trial
interval was 500 ms. Participants were instructed to focus on
the middle of the screen, concentrating only on the memory
task and ignoring the pictures during the delay. Effects of the
distractor valence on both speed and percentage errors were
analyzed to examine interference.
Childhood Trauma Questionnaire
The Childhood Trauma Questionnaire (CTQ) short form
(Bernstein et al. 2003; Thombs et al. 2009) is a 28-item retro-
spective self-report questionnaire developed to measure five
types of childhood maltreatment. The five types are emotion-
al, physical, and sexual abuse and emotional and physical
neglect. Each scale of the CTQ encloses five items that are
scored on five-point Likert scales with a maximum score of
25. The scales showed good reliability in the current sample
(Cronbach’s alphas > 0.75), except for the physical neglect
scale (Cronbach’s alpha = 0.50). Due to a technical error,
CTQ scores were only acquired for 56 participants (75%).
No differences between this group and the group without the
CTQ data were found on age or task performance (all ps
> .08). Given the healthy sample with a low prevalence of
childhood maltreatment, and hence highly skewed distribu-
tion of the CTQ data, instead of continuous scores, we made
use of the moderate-severe cutoff scores of the CTQ
(Bernstein et al. 2003; Heim et al. 2009a), to identify cases
with a positive history of childhood maltreatment (≥ 13 for
emotional abuse, ≥ 10 for physical abuse, ≥ 8 for sexual abuse,
≥ 15 for emotional neglect, and ≥ 10 for physical neglect). If
minimally 1 moderate to severe type of trauma was reported,
maltreatment was scored as present (n = 16; 9 placebo, 7
oxytocin), otherwise as no (/mild) maltreatment (n = 40; 19
placebo, 21 oxytocin).
Statistical analyses
Reaction times (RTs) of correct trials were checked for outliers
(more than two SD above the individual mean per type and
emotion), which were then replaced by the individual
mean ± two SD per type and emotion (4.4% of the total trials).
Mean RTs of correct trials and the percentage of errors were
analyzed using repeated measures (RM) analyses of variance
(ANOVA), with the within-subject factors emotion (neutral,
negative, and positive) and trial type (target present or absent)
and the between-subjects factor condition (oxytocin or place-
bo) in the full sample (N = 75). For exploratory analyses, the
factor maltreatment was included as a between-subjects factor
within the subset of individuals with these data available
(n = 56). The Greenhouse-Geisser correction was applied, if
the sphericity assumption was not met. Effect sizes (partial
ηp
2) are reported. The threshold for statistical significance
was set at p < .05 (two tailed).
Results
Reaction times
Table 1 shows reaction times for the correct trials with either a
target present or a target absent after neutral, negative, and
positive distractors in the placebo and oxytocin group. As
expected, the RM analyses on RTs in the full sample indicated
interference by both negative and positive distractors. That is,
participants were slower on trials with negative and positive
distractors (mean RTs = 1098 and 1060 ms, SDs = 16.8 and
17.4, respectively) compared to neutral images (mean
RTs = 1008 ms, SD = 17.5; main effect of emotion F(2,
146) = 41.42, p = < .001, ηp
2 = 0.36, post hoc comparisons
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ps < .001). Response times in target absent trials were slower
compared to target present trials (F(1, 73) = 68, 26, p < .001
ηp
2 = 0.48), and the effect of the emotional distractors was
stronger in the target absent trials (emotion by trial type
interaction F(2, 146) = 6.07, p = .003, ηp
2 = 0.077).
There was no significant main effect of condition, although
a trend was apparent (F(1, 73) = 3.64, p = .060, ηp
2 = 0.047),
indicating marginally slower reaction times in the oxytocin
condition (mean RT = 1087 ms, SD = 22.5) compared to
placebo (mean RT = 1025 ms, SD = 23.5). However, no
evidence was found for enhanced distraction by emotional
information after oxytocin administration, as the interaction
between condition and emotion was not significant (F(2,
146) = 0.92, p = .40, ηp
2 = 0.012), see Fig. 1.
Errors
Table 1 also shows the percentage of errors after neutral,
negative, and positive distractors on target present and target
absent trials in the placebo and oxytocin group. The RM
analyses on the percentage of errors in the full sample
indicated interference by negative distractors, but not by
positive distractors. That is, participants made more errors
on trials with negative distractors (mean percentage
error = 26.0, SD = 1.0) compared to neutral images (mean
percentage error = 13.4, SD = 1.0, F(1, 73) = 135.4,
p < .001, ηp
2 = 0.650), but not on trials with positive
distractors (mean percentage error = 14.5, SD = 0.9, F(1,
73) = 1.07, p = .30, ηp
2 = 0.014; main effect of emotion F(2,
146) = 87.11, p < .001, ηp
2 = 0.544). Furthermore, participants
mademore errors in the target present trials compared to target
absent trials (main effect of trial type F(1, 73) = 114.11,
p < .001, ηp
2 = 0.61), and the effect of the emotional
distractors was stronger in the target absent trials (emotion
by trial type interaction F(2, 146) = 11.71, p < .001,
ηp
2 = 0.138).
There was no main effect of condition (F(1, 73) = .001,
p = .98, ηp
2 < 0.001). Again, no evidence was found for an
enhanced distraction by emotional information after oxytocin
administration, as the interaction between condition and
emotion was not significant (F(2, 146) = 1.32, p = .27,
ηp
2 = 0.018).
Childhood maltreatment as a moderator
When childhood maltreatment history was added as a factor to
the RM analyses on RTs, there was no significant main effect
of condition (F(1, 52) = 2.01, p = .16, ηp
2 = 0.037), or of
maltreatment history (F(1, 52) = 0.23, p = .64, ηp
2 = 0.004),
and no condition by maltreatment history interaction (F(1,
52) = .14, p = .72, ηp
2 = 0.003). No interaction of condition
and maltreatment history with emotion was found either (F(2,
104) = 1.50, p = .23, ηp
2 = 0.028).
When maltreatment history was added as a factor to the
RM analyses on percentage of errors, there was again no main
effect of condition (F(1, 52) = 1.291, p = .26, ηp
2 = 0.024), but
there was a significant main effect of maltreatment history
(F(1, 52) = 8.81, p < .005, ηp
2 = 0.145). Participants who
experienced maltreatment were less accurate overall (mean
percentage error = 21.35, SD = 1.85) than those who experi-
enced no maltreatment (mean percentage error = 15.80,
SD = 0.86). There was furthermore a trend for a condition
by maltreatment history interaction (F(1, 52) = 3.15,
p = .082, ηp
2 = 0.057). Explorative follow-up analyses indi-
cated that participants reporting maltreatment made more er-
rors than those that did not report maltreatment in the placebo
condition (F(1,26) = 12.79, p = .001, ηp
2 = .33), but not within
the oxytocin condition (F(1, 26) = .632, p = .43, ηp
2 = 0.024),
see Fig. 2. However, within the maltreated group, no
Table 1 Mean RTs (SD) in milliseconds and percentage of errors (SD) on target present and target absent trials within the placebo and oxytocin group
Condition: Placebo (N = 36) Oxytocin (N = 39)
Distractor: Neutral Negative Positive Neutral Negative Positive
RT target present trials: 932 (127) 1014 (148) 948 (136) 995 (180) 1104 (172) 1034 (167)
RT target absent trials: 1037 (175) 1108 (175) 1109 (182) 1069 (169) 1167 (157) 1151 (181)
% Error target present trials: 21.3 (10.4) 27.8 (10.9) 20.8 (11.5) 20.5 (15.5) 28.8 (14.0) 21.2 (10.4)
% Error target absent trials: 7.4 (9.9) 22.7 (11.0) 7.6 (8.5) 4.5 (8.1) 24.6 (9.9) 8.3 (9.6)
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Fig. 1 Reaction times (ms) for correct trials per emotional distractor on
the working memory task in the placebo (n = 36) and oxytocin condition
(n = 39). Error bars represent standard errors
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significant difference was found between the placebo and the
oxytocin condition (F(1, 14) = 2.06, p = .17, ηp
2 = 0.13).
Lastly, no interaction of condition and maltreatment history
with emotion was found (F(2, 104) = .53, p = .59, ηp
2 = 0.01).
Discussion
The goal of this study was to examine whether oxytocin ad-
ministration would increase interference by emotional infor-
mation during a working memory task in healthy males. We
found no evidence of enhanced distraction by emotional in-
formation due to oxytocin on the working memory task.
Oxytocin did tend to slow down performance irrespective of
distractor valence, but this effect did not reach significance.
Furthermore, explorative follow-up analyses indicated that the
men reporting a history of childhood maltreatment made more
errors in the placebo condition, while they performed similar
to the group reporting no history of maltreatment in the
oxytocin condition.
As expected, the working memory task showed
interference by emotional information. That is, participants
responded more slowly after positive and negative distractors
compared to neutral distractors and made more errors after
negative compared to neutral distractors. This is in line with
previous findings showing that this task elicits emotional
interference during working memory performance (Krause-
Utz et al. 2012; Oei et al. 2010, 2012) and that emotions can
interact with cognitive processing (Cromheeke and Mueller
2014). However, in contrast to our expectations, oxytocin
did not enhance this emotional interference. While a number
of previous studies have indicated that oxytocin
administration can lead to augmented processing of emotional
information in behavioral tasks, as well as more during more
automatic cognitive processes (e.g., Schulze et al. 2011; Van
IJzendoorn and Bakermans-Kranenburg 2012; Domes et al.
2013; Tollenaar et al. 2013), others have shown contrasting
findings, including reduced attention to negative emotions and
null findings (Ellenbogen et al. 2012; Guastella et al. 2009b).
The current study does not show enhanced processing of emo-
tions in the context of a working memory task, which again
shows the seemingly contextual effects of oxytocin. While
these findings may also indicate that oxytocin does not reduce
cognitive mental performance in the context of emotional
distractors, future studies that examine a wider range of cog-
nitive tasks are recommended to fully elucidate the effects of
oxytocin on the interaction between cognitive performance
and emotional distractors, including different levels of cogni-
tive load and by including patient groups characterized by
emotional dysregulations.
Furthermore, we did find a slight, although non-significant,
indication for a slowdown in working memory performance
after oxytocin administration. As this reduced performance
was independent of distractor type, i.e., in both the neutral
and the emotional conditions, it does not appear to depend
on the emotional impact or social content of the task. More
general impairments in working memory performance after
oxytocin administration have previously been shown in ani-
mal research (Wirth 2015), and earlier research in humans also
suggests that oxytocin can impair memory for (non-social)
material (Heinrichs et al. 2004; Herzmann et al. 2012).
Wirth (2015) even suggested that oxytocin might exert some
of its effects on social behaviors in humans via temporarily
inhibiting or impairing working memory by effects on pre-
frontal brain areas. However, we cannot exclude the possibil-
ity that the slower performance after oxytocin administration
was due to slightly sedative effects of oxytocin, which have
been previously shown (Uvnäs-Moberg et al. 1994).
Furthermore, because we used a between-subjects design, this
small difference may have been due to baseline group
differences.
The most robust finding in the present study was that a
history of at least one type of moderate to severe childhood
maltreatment was associated with more errors on the task ir-
respective of distractor valence, while speed was unaffected.
This is in line with earlier studies showing associations be-
tween childhood trauma and cognitive functioning (DePrince
et al. 2009; Majer et al. 2010). However, a previous study with
the current working memory paradigm showed more specific
emotional interference in the group with a history of child-
hood maltreatment (Krause-Utz et al. 2012), although this
concerned a patient sample. Interestingly, the effect of mal-
treatment history on task accuracy in the current study was
most pronounced in the placebo condition; the maltreated
group performed similarly in accuracy to the not maltreated
group in the oxytocin condition, suggesting a possible bene-
ficial effect of oxytocin in the maltreated group may exist.
However, the sample size of the maltreated group was very
small, and performance between the oxytocin and placebo
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Fig. 2 Percentage errors on the workingmemory task in groups with and
without a history of maltreatment in the placebo (n = 19 and 9,
respectively) and oxytocin condition (n = 21 and 7, respectively). Error
bars represent standard errors; Double asterisks indicate p < .01
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condition within this group did not differ. Therefore, we can-
not draw any firm conclusions on the moderating role of mal-
treatment on the effects of oxytocin administration in the cur-
rent paradigm. Furthermore, several other studies that have
investigated the moderation of oxytocin effects by early life
stress have revealed reduced or even negative effects of oxy-
tocin on aspects of social behavior in people with a history of
early life stress (Fan et al. 2014; Riem et al. 2013; Van
IJzendoorn et al. 2011). Thus, when studying the potential
use of oxytocin as an additional therapy for stress-related dis-
orders like anxiety and depression (e.g., Guastella et al. 2009a;
Koch et al. 2014; McQuaid et al. 2014), it seems important to
examine childhood maltreatment as a possible moderator.
It has been suggested that the amygdala plays a role in the
effects of oxytocin on social and emotional task performance
(Meyer-Lindenberg et al. 2011; Wigton et al. 2015).
Maltreatment has also been associated with enhanced amyg-
dala reactivity in response to emotional information (van
Harmelen et al. 2013). However, the oxytocin and maltreat-
ment effects in this study were unrelated to the emotional
value of the distractors, and hence, it is unlikely that the cur-
rent findings are associated with effects on the amygdala. It
thus remains unclear whether the current findings are due to
general effects on (prefrontal related) working memory pro-
cesses, or are related to changes in the values of the distractors
with potential involvement of the amygdala. Debate continues
about the possible different routes by which oxytocin admin-
istration may affect behavioral outcomes, i.e., via the enhance-
ment of social salience (Shamay-Tsoory and Abu-Akel 2016),
by stimulating approach behaviors (Harari-Dahan and
Bernstein 2014), via more general anxiety reducing pathways,
or possibly via all of them (Quintana et al. 2015).
Some limitations of the current design should be noted. The
current findings are based on a relativity small sample,
especially with regard to the maltreatment group as discussed
previously. In addition, a between-subjects design was
employed, reducing power as well. Within-subjects designs
are preferred in pharmacological studies, but our experimental
tasks could not all be repeated and precluded the use of a
crossover design. We did explorative follow-up analyses of
the marginally significant interaction with maltreatment,
which should be interpreted with care. Another factor that
may be related to the non-significant effects is the timing of
the oxytocin administration, which was 80 min before the task
was performed. This was due to an EEG paradigm which was
employed before the working memory task (Ruissen and de
Bruijn 2015). The working memory task was performed last
in the study protocol, as the emotional distractors used in the
working memory paradigm can be perceived as stressful and
could have influenced later tests. However, cognitive and
emotional effects of oxytocin have been reported after similar
time spans (Olff et al. 2013). With regard to the emotional
working memory task, it may have been too easy to elicit
strong oxytocin effects, although there was an effect of emo-
tion on both speed and percentage errors. A more challenging
version of this task or another type of working memory task
could be included in future research. Further, only males were
included, and hence, these findings should be replicated in a
larger sample, including women as well. With regard to mal-
treatment as a moderator, future studies should include sam-
ples with more variance in amount and types of experienced
maltreatment history, or more specifically, participants could
be selected for maltreatment history and compared to a
matched control group. Controlling the effects of childhood
maltreatment for possible confounding by, e.g., social-
economic status or general cognitive abilities is also
recommended.
Conclusions
In the context of a working memory task, oxytocin did not
enhance distraction by emotional information. Individuals
with a maltreatment history made more errors overall, indicat-
ing possible problems in working memory for this group. We
suggest that effects of oxytocin onworking memory should be
further explored and could be considered in future studies
examining effects of oxytocin on social abilities to further
elucidate the pathways by which oxytocin exerts its effects.
Furthermore, childhood maltreatment should be considered as
a potential moderator.
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